The COVID-19 pandemic has initiated an unprecedented global research effort on a single virus. At Garvan, our researchers responded immediately to the pandemic. We are driving or collaborating on projects locally and globally to develop new ways to treat and prevent infection with coronavirus, and learn more about the virus to inform better global treatment strategies.

As there are no guarantees on which treatment or vaccine will be effective, researchers must take as many different approaches as possible.

Garvan’s excellence in antibody research, immunology, cellular genomics and whole genome sequencing is well positioned to contribute valuably to the global research effort to fight COVID-19. We are using cutting-edge technology to drive innovative research projects, with our focus firmly on improving outcomes for patients.

We will continue to update you on our COVID-19 research progress.

comments powered by Disqus

Join our community.

We're like-minded people making a world of difference.